Skip to main navigation Skip to search Skip to main content

Is AMH a promising predictive biomarker for mTESE success in iNOA patients?

  • Julia Uraji
  • , Juan J Fraire-Zamora
  • , Claudia Massarotti
  • , Sofia Makieva
  • , George Liperis
  • , Kashish Sharma
  • , Sarah Martins Da Silva
  • , Raevti Bole
  • , Jackson C. Kirkman-Brown
  • , Omar Farhan Ammar (Lead / Corresponding author)

Research output: Contribution to journalArticlepeer-review

28 Downloads (Pure)

Abstract

The September ESHRE Journal Club discussion focused on a study by Pozzi et al. that addressed the current standards in diagnostic male reproductive health, and whether or not AMH testing should be included in the future; what the possible mechanisms behind the link of AMH and sperm retrieval may be; how DCA can help us to understand prediction tools and models in clinical practice; and to what extent a high AMH level should alter the course of treatment in iNOA patients. AMH, anti-M€ ullerian hormone; iNOA, idiopathic non-obstructive azoospermia; DCA, decision curve analysis; mTESE, micro-dissection testicular sperm extraction.
Original languageEnglish
Article numberdeae179
Pages (from-to)2373-2378
Number of pages7
JournalHuman Reproduction
Volume39
Issue number10
Early online date7 Aug 2024
DOIs
Publication statusPublished - Oct 2024

Keywords

  • ESHREjc
  • Journal Club
  • mTESE
  • iNOA
  • biomarkers
  • AMH

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynaecology

Fingerprint

Dive into the research topics of 'Is AMH a promising predictive biomarker for mTESE success in iNOA patients?'. Together they form a unique fingerprint.

Cite this